Fragile X screening: Attitudes of genetic health professionals

American Journal of Medical Genetics, Part A

Volumn 149, Issue 4, 2009, Pages 626-632

  Acharya, Kruti ^a,b   Ross, Lainie Friedman ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Fragile X; Newborn screening; Population screening; Prenatal screening; Professional attitudes

Indexed keywords

ARTICLE; FAMILY HISTORY; FRAGILE X SYNDROME; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HETEROZYGOTE; LIFESPAN; NEWBORN SCREENING; PHYSICIAN ATTITUDE; PRENATAL SCREENING; PRIORITY JOURNAL;

ATTITUDE OF HEALTH PERSONNEL; CHILD; DATA COLLECTION; FEMALE; FRAGILE X SYNDROME; GENETIC COUNSELING; GENETIC SCREENING; GENETICS, MEDICAL; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 63749123267     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32725     Document Type: Article

References (54)

1. Acharya K, Ackerman PD, Ross LF. 2005. Pediatricians' attitudes toward expanding newborn screening. Pediatrics 116:e475-e482.
2. Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. 2008. Retrieved November 11, 2008, from http://www.hrsa.gov/heritabledisorderscommittee/default.htm.
3. American Academy of Pediatrics (AAP) Committee on Bioethics. 2001. Ethical Issues with Genetic Testing in Pediatrics. Pediatrics 107:1451-1455.
4. American College of Medical Genetics. 2005. Newborn screening towards a uniform screening panel and system-Report for public comment. Retrieved November 11, 2008, from ftp://ftp.hrsa.gov/mchb/genetics/screeningdraf tforcomment.pdf.
5. American College of Obstetricians and Gynecologists Committee on Genetics. 2006. ACOG committee opinion no. 338: Screening for Fragile X syndrome. Obstet Gynecol 107:1483-1485.
6. American Society of Human Genetics (ASHG)/American College of Medical Genetics (ACMG). 1995. Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 57:1233-1241.
7. Bailey DB Jr. 2004. Newborn screening for Fragile X syndrome. Ment Retard Dev Disabil Res Rev 10:3-10.
8. Bailey DB, Skinner D, Hatton D, Roberts J. 2000. Family experiences and factors associated with the diagnosis of fragile X syndrome. J Dev Behav Pediatr 21:315-321.
9. Bailey DB, Skinner D, Sparkman KL. 2003. Discovering fragile X syndrome: Family experiences and perceptions. Pediatrics 111:407-416.
10. Bailey DB Jr, Raspa M, Olmsted M, Holiday DB. 2008. Co-occurring conditions associated with FMR-1 gene variations-Findings from a National Parent Survey. Am J Med Genet Part A 146A:2060-2069.
11. Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, Hagerman RJ, Leehey MA. 2007. Fragile X-associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines. Mov Disord 22:2018-2030.
12. Boddington P, Gregory M. 2008. Adolescent Carrier Testing in Practice: The Impact of Legal Rulings and Problems with Gillick Competence. J Genet Counsel 17:509-521.
13. Chow JC, Chen DJ, Lin CN, Chiu CY, Huang CB, Chiu PC, Lin CH, Lin SJ, Tzeng CC. 2003. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan. J Formos Med Assoc 102:
14. 12-16.
15. Clarke A. 1994. The Genetic Testing of Children. Working Party of the Clinical Genetics Society (UK). J Med Genet 31:785-797.
16. Cooksey JA, Forte G, Benkendorf J, Blitzer MG. 2005. The state of the medical geneticist workforce: Findings of the 2003 survey of American Board of Medical Genetics certified geneticists. Genet Med 7:439-443.
17. Crawford DC, Meadows KL, Newman JL, Taft LF, Pettay DL, Gold LB, Hersey SJ, Hinkle EF, Stanfield ML, Holmgreen P, Yeargin-Allsopp M, Boyle C, Sherman SL. 1999. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet 64:495-507.
18. Cronister A, DiMaio M, Mahoney MJ, Donnenfeld AE, Hallam S. 2005. Fragile X syndrome carrier screening in the prenatal genetic counseling setting. Genet Med 7:246-250.
19. Dalby S. 1995. GIG response to the UK Clinical genetics Society report: ''The Genetic Testing of Children''. J Med Genet 32:490-494.
20. Dawson AJ, Chodirker BN, Chudley AE. 1995. Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots. Biochem Mol Med 56:63-69.
21. Fanos JH, Spangner KA, Musci TJ. 2006. Attitudes toward prenatal screening and testing for Fragile X. Genet Med 8:129-133.
22. Finlay WM, Lyons E. 2005. Rejecting the label: A social constructionist analysis. Mental Retard 43:120-134.
23. Frank Porter Graham Child Development Institute. 2008. Press Release: New Study Will Investigate Complex Social, Family Issues Surrounding Newborn Screening. Retrieved November 11, 2008, from http://www.fpg.unc.edu/news/ highlight-detail.cfm?ID=801.
24. Hagerman R, Hagerman PJ. 2002. Fragile X Syndrome: Diagnosis, treatment, and research. Baltimore: The Johns Hopkins University Press.
25. Hagerman PJ, Hagerman RJ. 2004a. Fragile X Associated Tremor/Ataxia Syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 10:25-30.
26. Hagerman PJ, Hagerman RJ. 2004b. The Fragile-X premutation: A maturing perspective. Am J Hum Genet 74:805-816.
27. Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, Tassone F, Hessl D, Harris SW, Zhang L, Jardini T, Gane LW, Ferranti J, Ruiz L, Leehey MA, Grigsby J, Hagerman PJ. 2004. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in Females with the FMR-1 premutation. Am J Hum Genet 74:1051-1056.
28. Hiraki S, Ormond KE, Kim K, Ross LF. 2006. Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children. Am J Med Genet Part A 140A:2312-2319
29. Hogben S, Boddington P. 2005. Policy recommendations for carrier testing and predictive testing in childhood: A distinction that makes a real difference. J Genet Counsel 14:271-281.
30. Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. 2007. Fragile-X syndrome and Fragile X-associated tremor/ataxia syndrome: Two faces of FMR1. Lancet Neurol 6:45-55.
31. Loesch DZ, Huggins RM, Hagerman RJ. 2004. Phenotypic variation and FMRP levels in fragile x. Ment Retard Dev Disabil Res Rev 10: 31-41.
32. McConkie-Rosell A, Spiridigliozzi GA, Melvin E, Dawson DV, Lachiewicz AM. 2008. Living with genetic risk: Effect on adolescent self-concept. Am J Med Genet Part C 148C:56-69.
33. Moeschler JB, Shevell M, American Academy of Pediatrics Committee on Genetics. 2006. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics 117:2304-2316.
34. Parrott S, Del Vecchio M. 2006. Professional Status Survey2006. Retrieved February 4, 2009 from: http://www.nsgc.org/client-files/career/2006-PSS- RESULTS.pdf.
35. Pesso R, Berkenstadt M, Cuckle H, Gak E, Peleg L, Frydman M, Barkai G. 2000. Screening for Fragile X syndrome in women of reproductive age. Prenat Diagn 20:611-614.
36. Rifé M, Mallolas J, Badenas C, Tazón B, Miguélez MR, Pàmpols T, Sànchez A, Milà M. 2002. Pilot study for the neonatal screening of fragile X syndrome. Prenat Diagn 22:459-462.
37. Rifé M, Badenas C, Mallolas J, Jiménez L, Cervera R, Maya A, Glover G, Rivera F, Milà M. 2003. Incidence of fragile X in 5,000 consecutive newborn males. Genet Testing 7:339-343.
38. Rosen A, Wallenstein S, McGovern MM. 2002. Attitudes of pediatric residents toward ethical issues associated with genetic testing in children. Pediatrics 110:360-363.
39. Ross LF. 2006. Screening for conditions that do not meet the Wilson and Jungner criteria: The case of Duchenne muscular dystrophy. Am J Med Genet Part A 140A:914-922.
40. Ross LF, Acharya K. 2008. Policy considerations in designing a fragile X newborn screening program. Genet Med 10:711-713.
41. Ryynanen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K. 1999. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 7:212-216.
42. Saul RA, Friez MJ, Eaves K, Gail A, Stapleton GA, Collins JS, Schwartz CE, Stevenson RE. 2008. Fragile X syndrome detection in newborns pilot study. Genet Med 10:714-719.
43. Sher C, Romano-Zelekha O, Green MS, Shohat T. 2003. Factors affecting performance of prenatal genetic testing by Israeli Jewish women. Am J Med Genet Part A 120A:418-422.
44. Sher C, Romano-Zelekha O, Green MS, Shohat T. 2004. Utilization of prenatal genetic testing by Israeli Moslem women: A national survey. Clin Genet 65:278-283.
45. Sherman SL. 2000. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97C:189-194.
46. Sherman S, Pletcher BA, Driscoll DA. 2005. Fragile X syndrome: Diagnostic and carrier testing. Genet Med 7:584-587.
47. Skinner D, Sparkman KL, Bailey DB Jr. 2003. Screening for fragile X syndrome: Parent attitudes and perspectives. Genet Med 5:378-384.
48. Strelnikov V, Nemtsova M, Chesnokova G, Kuleshov N, Zaletayev D. 1999. A simple multiplex FRAXA, FRAXE, and FRAXF PCR assay convenient for wide screening programs. Hum Mutat 13:166-169.
49. Strom CM, Huang D, Li Y, Hantash FM, Rooke J, Potts SJ, Sun W. 2007.
50. Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for fragile X syndrome. Genet Med 9:199-207.
51. Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ. 2008. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 10:43-49.
52. The Centers for Disease Control and Prevention (CDC). 2006. Single Gene Disorders and Disabilities (SGDD) CDC Priorities. ''What is CDC doing about FXS?'' Retrieved on November 11, 2008 from http://www.cdc.gov/ncbddd/single- gene/fragilex-cdc.htm.
53. UC Davis Health System. 2008. ''UC Davis M.I.N.D. Institute researchers to begin widespread newborn screening for fragile X syndrome''. Retrieved November 11, 2008 from http://www.ucdmc.ucdavis.edu/welcome/features/20081022- newborn-screening/index.html.
54. Wilson JMG, Jungner F. 1968. Principles and practice of screening for disease. Public Health Papers, no. 34. Geneva: World Health Organization.